Skip to content

Sana Biotechnology SANA Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$109.92B-9.5%
Gilead Sciences logo
Gilead SciencesGILD
$187.53B+19.7%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$4.93B+69.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$787.38M+114%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$1.46B+100%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$912.8M+55.1%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Calculated from Sana Biotechnology’s reported figures.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's enterprise value?
Sana Biotechnology (SANA) reported enterprise value of $760.1M in Q1 2026.
How has Sana Biotechnology's enterprise value changed year-over-year?
Sana Biotechnology's enterprise value increased by 103.7% year-over-year, from $373.22M to $760.1M.
What is the long-term trend for Sana Biotechnology's enterprise value?
Over 4 years (2021 to 2025), Sana Biotechnology's enterprise value has grown at a -20.5% compound annual growth rate (CAGR), from $2.74B to $1.09B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.